Saturday, October 10, 2026
26.2 C
Bengaluru

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of marketing. It suffers from a shortage of trustworthy information patients can use when decisions are urgent, expensive, and consequential.

MedicinMan’s latest Intelligence Report brings together issues that are usually discussed separately:

Pharma promotion. Hospital advertising. Cancer-drug pricing. Medical devices and consumables. Regulatory accountability. And healthcare trust itself.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

The next owner of an Indian hospital may not...

Indian Pharma’s Three Deficits—and Three Potential Dividends

Indian pharma has already done the hard thing once. It...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

Topics

spot_img

Related Articles

spot_imgspot_img